モルヌピラビル (メルク社)†
- コロナ飲み薬、重症化リスク半減 メルク、米で使用許可申請へ
PF-07321332 (ファイザー)†
- First Participant Dosed in Phase 2/3 Study of Oral Antiviral Candidate in Non-Hospitalized Adults with COVID-19 Who Are at Low Risk of Severe Illness
- https://cdn.pfizer.com/pfizercom/2021-09/First_Participant_Dosed_in_Phase_2_3.pdf
PF-07321332 – an investigational orally administered protease inhibitor antiviral therapy designed specifically to combat COVID-19
- https://cdn.pfizer.com/pfizercom/2021-09/First_Participant_Dosed_in_Phase_2_3.pdf
イベルメクチン (北里大学、メルク社)†
- 駆虫薬「イベルメクチン」、米でコロナ治療目的の使用に警鐘
ロナプリーブ (中外製薬)†
- 中外製薬ロナプリーブ「コロナ第4の薬」の正体